Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release

Osteosarcoma (OS) accounts for 60% of all global bone cancer diagnoses. Intravenous administration of Doxorubicin Hydrochloride (DOXO) is the current form of OS treatment, however, systemic delivery has been linked to the onset of DOXO induced cardiomyopathy. Biomaterials including calcium phosphate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Bioeng Biotechnol
Hlavní autoři: Dewhurst, Rebecca Marie, Scalzone, Annachiara, Buckley, Joseph, Mattu, Clara, Rankin, Kenneth S., Gentile, Piergiorgio, Ferreira, Ana Marina
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Bioengineering and Biotechnology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7363953/
https://ncbi.nlm.nih.gov/pubmed/32733869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00754
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky